BANK OF MONTREAL /CAN/ - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 33 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,176,000
-51.2%
65,730
-73.1%
0.00%
-100.0%
Q2 2021$2,410,000
-12.6%
244,382
-0.9%
0.00%
-50.0%
Q1 2021$2,759,000
+14.2%
246,689
+46.3%
0.00%0.0%
Q4 2020$2,415,000
+3.2%
168,639
+9.5%
0.00%0.0%
Q3 2020$2,340,000
+7700.0%
153,947
+3670.4%
0.00%
Q2 2020$30,000
+57.9%
4,083
-77.7%
0.00%
Q4 2019$19,000
+216.7%
18,3330.0%0.00%
Q3 2019$6,000
+500.0%
18,333
+37314.3%
0.00%
Q3 2016$1,000
-50.0%
49
-75.5%
0.00%
Q2 2016$2,000
+100.0%
200
+354.5%
0.00%
Q3 2015$1,000440.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders